Our nominally significant finding for NKG2A+ natural killer cells may imply their immune regulatory mechanisms in AD risk; NKG2A, if expressed on natural killer cells, binds to HLA class I molecules on healthy, intact cells and prevents cytotoxic attacks. The gene discussed is KLRC1; the disease is Alzheimer disease.